2cureX AB (publ) (2CUREX.ST) Research
Based in Copenhagen, Denmark, 2cureX AB (publ) is a European medtech firm established in 2006. The company's core offering is IndiTreat, an in-vitro diagnostic test designed to forecast how cancer patients will respond to or resist various drug treatments, thereby guiding clinicians in selecting the most effective therapy. Additionally, 2cureX is actively advancing IndiTreat through clinical programs targeting a range of cancers, including breast, colorectal, ovarian, and pancreatic types.
Market snapshot
- Symbol
- 2CUREX.ST
- Price
- $1.91
- Day change
- -4.98%
- Market cap
- $47.9M
- Sector
- Healthcare
- Industry
- Biotechnology
Open 2cureX AB (publ) (2CUREX.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.